Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
Clinical trial NCT04948203 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04948203
- Sponsor
- University of Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-09
- Primary completion
- 2026-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.